ISTURISA
Mark Identification

ISTURISA

Serial Number

79187535

Filing Date

Mar 30, 2016

Registration Date

Oct 18, 2016

Trademark by

RECORDATI AG

Active Trademark

Classification Information

[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics ; anti-fungal preparations ; antivirals ; cardiovascular pharmaceuticals ; dermatological pharmaceutical products ; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system ; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases ; ] pharmaceutical preparations for the prevention and treatment of diseases and disorders of [ the autoimmune system, ] the metabolic system, the endocrine system [, the musculoskeletal system and the genitourinary system ; pharmaceutical preparations for use in hematology and in tissue and organ transplantation ; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions ; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders ; pharmaceutical preparations for the prevention and treatment of kidney diseases ; pharmaceutical preparations for the prevention and treatment of diabetes ; pharmaceutical preparations for the prevention and treatment of hypertension ; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology ; pharmaceutical preparations for use in urology ; pharmaceutical products for ophthalmological use ; pharmaceutical products for the prevention and treatment of cancer and tumors ; Pharmaceutical preparations for the prevention and treatment of allergies ; pharmaceutical products for the prevention and treatment of bone diseases ; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma ]

Pharmaceuticals